Otsuka T, Nishida S, Shibahara T, Temizoz B, et al. CpG ODN (K3)-toll-like receptor 9 agonist-induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I study. BMC Cancer 2022;22:744.
PMID: 35799134